Lyka Labs secures Indian patent for Pregabalin Gel 8%
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
The products will be manufactured in Goa India and marketed & distributed in Australian markets
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
Nipaguard SCE Vita delivers comprehensive antimicrobial protection for personal care formulations
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Havix was incorporated under the laws of the State of Delaware on February 17, 2015
Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
Subscribe To Our Newsletter & Stay Updated